nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC15A1—epithelium—ovarian cancer	0.00307	0.11	CbGeAlD
Cefepime—SLC15A1—endometrium—ovarian cancer	0.00276	0.0983	CbGeAlD
Cefepime—SLC22A5—myometrium—ovarian cancer	0.00213	0.0759	CbGeAlD
Cefepime—SLC15A1—vagina—ovarian cancer	0.00206	0.0736	CbGeAlD
Cefepime—Urticaria—Chlorambucil—ovarian cancer	0.00191	0.00197	CcSEcCtD
Cefepime—Dyspnoea—Topotecan—ovarian cancer	0.00191	0.00197	CcSEcCtD
Cefepime—SLC15A2—uterine cervix—ovarian cancer	0.0019	0.0679	CbGeAlD
Cefepime—Body temperature increased—Chlorambucil—ovarian cancer	0.0019	0.00196	CcSEcCtD
Cefepime—Abdominal pain—Chlorambucil—ovarian cancer	0.0019	0.00196	CcSEcCtD
Cefepime—Renal failure—Paclitaxel—ovarian cancer	0.0019	0.00196	CcSEcCtD
Cefepime—Colitis—Epirubicin—ovarian cancer	0.0019	0.00195	CcSEcCtD
Cefepime—Candida infection—Epirubicin—ovarian cancer	0.00189	0.00194	CcSEcCtD
Cefepime—Inflammation—Doxorubicin—ovarian cancer	0.00189	0.00194	CcSEcCtD
Cefepime—Paraesthesia—Melphalan—ovarian cancer	0.00189	0.00194	CcSEcCtD
Cefepime—Urinary tract infection—Paclitaxel—ovarian cancer	0.00188	0.00193	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00188	0.00193	CcSEcCtD
Cefepime—Dyspnoea—Melphalan—ovarian cancer	0.00187	0.00193	CcSEcCtD
Cefepime—Vaginal infection—Epirubicin—ovarian cancer	0.00187	0.00192	CcSEcCtD
Cefepime—Aplastic anaemia—Epirubicin—ovarian cancer	0.00186	0.00191	CcSEcCtD
Cefepime—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00185	0.0019	CcSEcCtD
Cefepime—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00183	0.00189	CcSEcCtD
Cefepime—Constipation—Topotecan—ovarian cancer	0.00183	0.00189	CcSEcCtD
Cefepime—Pain—Topotecan—ovarian cancer	0.00183	0.00189	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00183	0.00188	CcSEcCtD
Cefepime—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00183	0.00188	CcSEcCtD
Cefepime—Infection—Vinorelbine—ovarian cancer	0.00182	0.00188	CcSEcCtD
Cefepime—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00181	0.00187	CcSEcCtD
Cefepime—Coma—Epirubicin—ovarian cancer	0.00181	0.00186	CcSEcCtD
Cefepime—Thrombocytopenia—Vinorelbine—ovarian cancer	0.0018	0.00185	CcSEcCtD
Cefepime—Pain—Melphalan—ovarian cancer	0.0018	0.00185	CcSEcCtD
Cefepime—Hypersensitivity—Chlorambucil—ovarian cancer	0.00177	0.00183	CcSEcCtD
Cefepime—Feeling abnormal—Topotecan—ovarian cancer	0.00177	0.00182	CcSEcCtD
Cefepime—Colitis—Doxorubicin—ovarian cancer	0.00176	0.00181	CcSEcCtD
Cefepime—Gastrointestinal pain—Topotecan—ovarian cancer	0.00175	0.0018	CcSEcCtD
Cefepime—Candida infection—Doxorubicin—ovarian cancer	0.00175	0.0018	CcSEcCtD
Cefepime—Pancytopenia—Docetaxel—ovarian cancer	0.00175	0.0018	CcSEcCtD
Cefepime—Haemoglobin—Paclitaxel—ovarian cancer	0.00175	0.0018	CcSEcCtD
Cefepime—Haemorrhage—Paclitaxel—ovarian cancer	0.00174	0.00179	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—ovarian cancer	0.00173	0.00178	CcSEcCtD
Cefepime—SLC15A2—endometrium—ovarian cancer	0.00172	0.0614	CbGeAlD
Cefepime—Neutropenia—Docetaxel—ovarian cancer	0.00172	0.00177	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00172	0.00177	CcSEcCtD
Cefepime—Sepsis—Epirubicin—ovarian cancer	0.00172	0.00177	CcSEcCtD
Cefepime—Pruritus—Chlorambucil—ovarian cancer	0.0017	0.00175	CcSEcCtD
Cefepime—Urticaria—Topotecan—ovarian cancer	0.0017	0.00175	CcSEcCtD
Cefepime—Body temperature increased—Topotecan—ovarian cancer	0.0017	0.00174	CcSEcCtD
Cefepime—Abdominal pain—Topotecan—ovarian cancer	0.0017	0.00174	CcSEcCtD
Cefepime—Coma—Doxorubicin—ovarian cancer	0.00167	0.00172	CcSEcCtD
Cefepime—Urticaria—Melphalan—ovarian cancer	0.00167	0.00172	CcSEcCtD
Cefepime—Phlebitis—Epirubicin—ovarian cancer	0.00167	0.00171	CcSEcCtD
Cefepime—SLC22A5—uterine cervix—ovarian cancer	0.00166	0.0591	CbGeAlD
Cefepime—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.00165	0.0017	CcSEcCtD
Cefepime—Pneumonia—Docetaxel—ovarian cancer	0.00165	0.0017	CcSEcCtD
Cefepime—Diarrhoea—Chlorambucil—ovarian cancer	0.00165	0.0017	CcSEcCtD
Cefepime—Paraesthesia—Vinorelbine—ovarian cancer	0.00165	0.00169	CcSEcCtD
Cefepime—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00164	0.00169	CcSEcCtD
Cefepime—Erythema multiforme—Paclitaxel—ovarian cancer	0.00164	0.00169	CcSEcCtD
Cefepime—Dyspnoea—Vinorelbine—ovarian cancer	0.00164	0.00168	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00163	0.00167	CcSEcCtD
Cefepime—Renal failure—Docetaxel—ovarian cancer	0.00161	0.00166	CcSEcCtD
Cefepime—Hepatic failure—Epirubicin—ovarian cancer	0.0016	0.00164	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—ovarian cancer	0.00159	0.00163	CcSEcCtD
Cefepime—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00158	0.00163	CcSEcCtD
Cefepime—Hypersensitivity—Topotecan—ovarian cancer	0.00158	0.00163	CcSEcCtD
Cefepime—Constipation—Vinorelbine—ovarian cancer	0.00157	0.00161	CcSEcCtD
Cefepime—Pain—Vinorelbine—ovarian cancer	0.00157	0.00161	CcSEcCtD
Cefepime—Chills—Paclitaxel—ovarian cancer	0.00156	0.0016	CcSEcCtD
Cefepime—Hypersensitivity—Melphalan—ovarian cancer	0.00155	0.00159	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—ovarian cancer	0.00154	0.00159	CcSEcCtD
Cefepime—Vomiting—Chlorambucil—ovarian cancer	0.00153	0.00158	CcSEcCtD
Cefepime—Agranulocytosis—Docetaxel—ovarian cancer	0.00153	0.00157	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00153	0.00157	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00152	0.00156	CcSEcCtD
Cefepime—Pruritus—Topotecan—ovarian cancer	0.00152	0.00156	CcSEcCtD
Cefepime—Erythema—Paclitaxel—ovarian cancer	0.00151	0.00156	CcSEcCtD
Cefepime—Feeling abnormal—Vinorelbine—ovarian cancer	0.00151	0.00156	CcSEcCtD
Cefepime—Renal impairment—Epirubicin—ovarian cancer	0.00151	0.00155	CcSEcCtD
Cefepime—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.0015	0.00154	CcSEcCtD
Cefepime—SLC22A5—endometrium—ovarian cancer	0.0015	0.0534	CbGeAlD
Cefepime—Pruritus—Melphalan—ovarian cancer	0.00149	0.00153	CcSEcCtD
Cefepime—Dysgeusia—Paclitaxel—ovarian cancer	0.00148	0.00152	CcSEcCtD
Cefepime—Haemoglobin—Docetaxel—ovarian cancer	0.00148	0.00152	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—ovarian cancer	0.00148	0.00152	CcSEcCtD
Cefepime—Haemorrhage—Docetaxel—ovarian cancer	0.00147	0.00151	CcSEcCtD
Cefepime—Diarrhoea—Topotecan—ovarian cancer	0.00147	0.00151	CcSEcCtD
Cefepime—Urticaria—Vinorelbine—ovarian cancer	0.00146	0.0015	CcSEcCtD
Cefepime—Body temperature increased—Vinorelbine—ovarian cancer	0.00145	0.00149	CcSEcCtD
Cefepime—Abdominal pain—Vinorelbine—ovarian cancer	0.00145	0.00149	CcSEcCtD
Cefepime—Diarrhoea—Melphalan—ovarian cancer	0.00144	0.00148	CcSEcCtD
Cefepime—Nausea—Chlorambucil—ovarian cancer	0.00143	0.00147	CcSEcCtD
Cefepime—SLC15A2—female reproductive system—ovarian cancer	0.00143	0.0509	CbGeAlD
Cefepime—Dizziness—Topotecan—ovarian cancer	0.00142	0.00146	CcSEcCtD
Cefepime—Anaemia—Paclitaxel—ovarian cancer	0.0014	0.00144	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—ovarian cancer	0.0014	0.00144	CcSEcCtD
Cefepime—Erythema multiforme—Docetaxel—ovarian cancer	0.00139	0.00143	CcSEcCtD
Cefepime—Agitation—Paclitaxel—ovarian cancer	0.00139	0.00143	CcSEcCtD
Cefepime—Vomiting—Topotecan—ovarian cancer	0.00136	0.0014	CcSEcCtD
Cefepime—Leukopenia—Paclitaxel—ovarian cancer	0.00135	0.00139	CcSEcCtD
Cefepime—Rash—Topotecan—ovarian cancer	0.00135	0.00139	CcSEcCtD
Cefepime—Hypersensitivity—Vinorelbine—ovarian cancer	0.00135	0.00139	CcSEcCtD
Cefepime—Dermatitis—Topotecan—ovarian cancer	0.00135	0.00139	CcSEcCtD
Cefepime—Headache—Topotecan—ovarian cancer	0.00134	0.00138	CcSEcCtD
Cefepime—Vomiting—Melphalan—ovarian cancer	0.00134	0.00137	CcSEcCtD
Cefepime—Rash—Melphalan—ovarian cancer	0.00132	0.00136	CcSEcCtD
Cefepime—Dermatitis—Melphalan—ovarian cancer	0.00132	0.00136	CcSEcCtD
Cefepime—Chills—Docetaxel—ovarian cancer	0.00132	0.00136	CcSEcCtD
Cefepime—Convulsion—Paclitaxel—ovarian cancer	0.00131	0.00135	CcSEcCtD
Cefepime—SLC15A2—female gonad—ovarian cancer	0.0013	0.0463	CbGeAlD
Cefepime—Pruritus—Vinorelbine—ovarian cancer	0.0013	0.00134	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00129	0.00133	CcSEcCtD
Cefepime—SLC15A2—vagina—ovarian cancer	0.00129	0.046	CbGeAlD
Cefepime—Erythema—Docetaxel—ovarian cancer	0.00128	0.00132	CcSEcCtD
Cefepime—Nausea—Topotecan—ovarian cancer	0.00127	0.00131	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00127	0.0013	CcSEcCtD
Cefepime—Diarrhoea—Vinorelbine—ovarian cancer	0.00126	0.00129	CcSEcCtD
Cefepime—Dysgeusia—Docetaxel—ovarian cancer	0.00126	0.00129	CcSEcCtD
Cefepime—Nausea—Melphalan—ovarian cancer	0.00125	0.00128	CcSEcCtD
Cefepime—Confusional state—Paclitaxel—ovarian cancer	0.00124	0.00128	CcSEcCtD
Cefepime—SLC22A5—female reproductive system—ovarian cancer	0.00124	0.0443	CbGeAlD
Cefepime—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00123	0.00127	CcSEcCtD
Cefepime—Eosinophilia—Epirubicin—ovarian cancer	0.00123	0.00126	CcSEcCtD
Cefepime—Infection—Paclitaxel—ovarian cancer	0.00123	0.00126	CcSEcCtD
Cefepime—Shock—Paclitaxel—ovarian cancer	0.00121	0.00125	CcSEcCtD
Cefepime—Dizziness—Vinorelbine—ovarian cancer	0.00121	0.00125	CcSEcCtD
Cefepime—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.0012	0.00123	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—ovarian cancer	0.00119	0.00123	CcSEcCtD
Cefepime—Anaemia—Docetaxel—ovarian cancer	0.00118	0.00122	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—ovarian cancer	0.00118	0.00121	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00117	0.00121	CcSEcCtD
Cefepime—Vomiting—Vinorelbine—ovarian cancer	0.00117	0.0012	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—ovarian cancer	0.00116	0.00119	CcSEcCtD
Cefepime—Rash—Vinorelbine—ovarian cancer	0.00116	0.00119	CcSEcCtD
Cefepime—Dermatitis—Vinorelbine—ovarian cancer	0.00116	0.00119	CcSEcCtD
Cefepime—SLC15A2—testis—ovarian cancer	0.00115	0.0411	CbGeAlD
Cefepime—Headache—Vinorelbine—ovarian cancer	0.00115	0.00118	CcSEcCtD
Cefepime—Leukopenia—Docetaxel—ovarian cancer	0.00115	0.00118	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—ovarian cancer	0.00114	0.00117	CcSEcCtD
Cefepime—SLC22A5—female gonad—ovarian cancer	0.00113	0.0403	CbGeAlD
Cefepime—SLC22A5—vagina—ovarian cancer	0.00112	0.04	CbGeAlD
Cefepime—Pneumonia—Epirubicin—ovarian cancer	0.00111	0.00114	CcSEcCtD
Cefepime—Convulsion—Docetaxel—ovarian cancer	0.00111	0.00114	CcSEcCtD
Cefepime—Paraesthesia—Paclitaxel—ovarian cancer	0.00111	0.00114	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—ovarian cancer	0.0011	0.00114	CcSEcCtD
Cefepime—Dyspnoea—Paclitaxel—ovarian cancer	0.0011	0.00113	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.0011	0.00113	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—ovarian cancer	0.00109	0.00112	CcSEcCtD
Cefepime—Nausea—Vinorelbine—ovarian cancer	0.00109	0.00112	CcSEcCtD
Cefepime—Renal failure—Epirubicin—ovarian cancer	0.00109	0.00112	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—ovarian cancer	0.00108	0.00111	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—ovarian cancer	0.00107	0.0011	CcSEcCtD
Cefepime—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00107	0.0011	CcSEcCtD
Cefepime—Pain—Paclitaxel—ovarian cancer	0.00106	0.00109	CcSEcCtD
Cefepime—Constipation—Paclitaxel—ovarian cancer	0.00106	0.00109	CcSEcCtD
Cefepime—Confusional state—Docetaxel—ovarian cancer	0.00105	0.00109	CcSEcCtD
Cefepime—Anaphylactic shock—Docetaxel—ovarian cancer	0.00105	0.00108	CcSEcCtD
Cefepime—Infection—Docetaxel—ovarian cancer	0.00104	0.00107	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Cefepime—Shock—Docetaxel—ovarian cancer	0.00103	0.00106	CcSEcCtD
Cefepime—Thrombocytopenia—Docetaxel—ovarian cancer	0.00102	0.00105	CcSEcCtD
Cefepime—Feeling abnormal—Paclitaxel—ovarian cancer	0.00102	0.00105	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00101	0.00104	CcSEcCtD
Cefepime—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00101	0.00104	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—ovarian cancer	0.00101	0.00104	CcSEcCtD
Cefepime—SLC22A5—testis—ovarian cancer	0.001	0.0357	CbGeAlD
Cefepime—Haemoglobin—Epirubicin—ovarian cancer	0.000998	0.00103	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—ovarian cancer	0.000995	0.00102	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—ovarian cancer	0.000993	0.00102	CcSEcCtD
Cefepime—Urticaria—Paclitaxel—ovarian cancer	0.00098	0.00101	CcSEcCtD
Cefepime—Abdominal pain—Paclitaxel—ovarian cancer	0.000976	0.001	CcSEcCtD
Cefepime—Body temperature increased—Paclitaxel—ovarian cancer	0.000976	0.001	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—ovarian cancer	0.000955	0.000983	CcSEcCtD
Cefepime—Paraesthesia—Docetaxel—ovarian cancer	0.000939	0.000966	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—ovarian cancer	0.000939	0.000966	CcSEcCtD
Cefepime—Dyspnoea—Docetaxel—ovarian cancer	0.000933	0.000959	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—ovarian cancer	0.000923	0.00095	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—ovarian cancer	0.000919	0.000945	CcSEcCtD
Cefepime—Hypersensitivity—Paclitaxel—ovarian cancer	0.000909	0.000935	CcSEcCtD
Cefepime—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000903	0.000929	CcSEcCtD
Cefepime—Constipation—Docetaxel—ovarian cancer	0.000894	0.00092	CcSEcCtD
Cefepime—Pain—Docetaxel—ovarian cancer	0.000894	0.00092	CcSEcCtD
Cefepime—Chills—Epirubicin—ovarian cancer	0.000891	0.000917	CcSEcCtD
Cefepime—Pruritus—Paclitaxel—ovarian cancer	0.000873	0.000898	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—ovarian cancer	0.000869	0.000894	CcSEcCtD
Cefepime—Erythema—Epirubicin—ovarian cancer	0.000864	0.000889	CcSEcCtD
Cefepime—Feeling abnormal—Docetaxel—ovarian cancer	0.000862	0.000887	CcSEcCtD
Cefepime—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000855	0.00088	CcSEcCtD
Cefepime—Dysgeusia—Epirubicin—ovarian cancer	0.000847	0.000871	CcSEcCtD
Cefepime—Diarrhoea—Paclitaxel—ovarian cancer	0.000844	0.000869	CcSEcCtD
Cefepime—SLC15A2—lymph node—ovarian cancer	0.000835	0.0298	CbGeAlD
Cefepime—Body temperature increased—Docetaxel—ovarian cancer	0.000827	0.000851	CcSEcCtD
Cefepime—Abdominal pain—Docetaxel—ovarian cancer	0.000827	0.000851	CcSEcCtD
Cefepime—Chills—Doxorubicin—ovarian cancer	0.000824	0.000848	CcSEcCtD
Cefepime—Dizziness—Paclitaxel—ovarian cancer	0.000816	0.00084	CcSEcCtD
Cefepime—Erythema—Doxorubicin—ovarian cancer	0.0008	0.000823	CcSEcCtD
Cefepime—Anaemia—Epirubicin—ovarian cancer	0.000799	0.000822	CcSEcCtD
Cefepime—Agitation—Epirubicin—ovarian cancer	0.000794	0.000817	CcSEcCtD
Cefepime—Vomiting—Paclitaxel—ovarian cancer	0.000785	0.000807	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—ovarian cancer	0.000783	0.000806	CcSEcCtD
Cefepime—Rash—Paclitaxel—ovarian cancer	0.000778	0.000801	CcSEcCtD
Cefepime—Dermatitis—Paclitaxel—ovarian cancer	0.000777	0.0008	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—ovarian cancer	0.000774	0.000796	CcSEcCtD
Cefepime—Headache—Paclitaxel—ovarian cancer	0.000773	0.000795	CcSEcCtD
Cefepime—Hypersensitivity—Docetaxel—ovarian cancer	0.000771	0.000793	CcSEcCtD
Cefepime—Convulsion—Epirubicin—ovarian cancer	0.000749	0.000771	CcSEcCtD
Cefepime—Pruritus—Docetaxel—ovarian cancer	0.00074	0.000761	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—ovarian cancer	0.000739	0.000761	CcSEcCtD
Cefepime—Agitation—Doxorubicin—ovarian cancer	0.000735	0.000756	CcSEcCtD
Cefepime—Nausea—Paclitaxel—ovarian cancer	0.000733	0.000754	CcSEcCtD
Cefepime—SLC22A5—lymph node—ovarian cancer	0.000726	0.0259	CbGeAlD
Cefepime—Leukopenia—Doxorubicin—ovarian cancer	0.000716	0.000737	CcSEcCtD
Cefepime—Diarrhoea—Docetaxel—ovarian cancer	0.000716	0.000736	CcSEcCtD
Cefepime—Confusional state—Epirubicin—ovarian cancer	0.000711	0.000732	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—ovarian cancer	0.000705	0.000726	CcSEcCtD
Cefepime—Infection—Epirubicin—ovarian cancer	0.000701	0.000721	CcSEcCtD
Cefepime—Shock—Epirubicin—ovarian cancer	0.000694	0.000714	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—ovarian cancer	0.000693	0.000713	CcSEcCtD
Cefepime—Dizziness—Docetaxel—ovarian cancer	0.000692	0.000712	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—ovarian cancer	0.000691	0.000711	CcSEcCtD
Cefepime—Vomiting—Docetaxel—ovarian cancer	0.000665	0.000684	CcSEcCtD
Cefepime—Rash—Docetaxel—ovarian cancer	0.000659	0.000679	CcSEcCtD
Cefepime—Dermatitis—Docetaxel—ovarian cancer	0.000659	0.000678	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—ovarian cancer	0.000658	0.000677	CcSEcCtD
Cefepime—Headache—Docetaxel—ovarian cancer	0.000655	0.000674	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000653	0.000672	CcSEcCtD
Cefepime—Infection—Doxorubicin—ovarian cancer	0.000649	0.000667	CcSEcCtD
Cefepime—Shock—Doxorubicin—ovarian cancer	0.000642	0.000661	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000639	0.000658	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—ovarian cancer	0.000633	0.000652	CcSEcCtD
Cefepime—Dyspnoea—Epirubicin—ovarian cancer	0.000629	0.000647	CcSEcCtD
Cefepime—Nausea—Docetaxel—ovarian cancer	0.000621	0.000639	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000609	0.000627	CcSEcCtD
Cefepime—Constipation—Epirubicin—ovarian cancer	0.000603	0.000621	CcSEcCtD
Cefepime—Pain—Epirubicin—ovarian cancer	0.000603	0.000621	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—ovarian cancer	0.000586	0.000603	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—ovarian cancer	0.000582	0.000599	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—ovarian cancer	0.000581	0.000598	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000577	0.000594	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000564	0.00058	CcSEcCtD
Cefepime—Urticaria—Epirubicin—ovarian cancer	0.00056	0.000577	CcSEcCtD
Cefepime—Pain—Doxorubicin—ovarian cancer	0.000558	0.000574	CcSEcCtD
Cefepime—Constipation—Doxorubicin—ovarian cancer	0.000558	0.000574	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—ovarian cancer	0.000558	0.000574	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—ovarian cancer	0.000558	0.000574	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—ovarian cancer	0.000538	0.000553	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000534	0.000549	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—ovarian cancer	0.00052	0.000535	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—ovarian cancer	0.000519	0.000534	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—ovarian cancer	0.000516	0.000531	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—ovarian cancer	0.000516	0.000531	CcSEcCtD
Cefepime—Pruritus—Epirubicin—ovarian cancer	0.000499	0.000514	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—ovarian cancer	0.000483	0.000497	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—ovarian cancer	0.000481	0.000495	CcSEcCtD
Cefepime—Dizziness—Epirubicin—ovarian cancer	0.000467	0.00048	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—ovarian cancer	0.000462	0.000475	CcSEcCtD
Cefepime—Vomiting—Epirubicin—ovarian cancer	0.000449	0.000462	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—ovarian cancer	0.000447	0.00046	CcSEcCtD
Cefepime—Rash—Epirubicin—ovarian cancer	0.000445	0.000458	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—ovarian cancer	0.000444	0.000457	CcSEcCtD
Cefepime—Headache—Epirubicin—ovarian cancer	0.000442	0.000455	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—ovarian cancer	0.000432	0.000444	CcSEcCtD
Cefepime—Nausea—Epirubicin—ovarian cancer	0.000419	0.000431	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—ovarian cancer	0.000415	0.000427	CcSEcCtD
Cefepime—Rash—Doxorubicin—ovarian cancer	0.000412	0.000423	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—ovarian cancer	0.000411	0.000423	CcSEcCtD
Cefepime—Headache—Doxorubicin—ovarian cancer	0.000409	0.000421	CcSEcCtD
Cefepime—Nausea—Doxorubicin—ovarian cancer	0.000388	0.000399	CcSEcCtD
